Tag Archives: respiratory syncytial virus

MedImmune and Sanofi Pasteur to jointly develop and commercialise respiratory syncytial virus monoclonal antibody

LONDON, 03-Mar-2017 — /EuropaWire/ — MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, today announced an agreement to develop and commercialise MEDI8897 jointly. MEDI8897 is a monoclonal antibody (mAb) for the … Read the full press release